baber/WOPTO huggingface dataset:
Patent CA-2322050-A1 (CA)
Title: Expandable stent
Inventor: ROSS STEPHEN O
IPC: A61F2/92
Filed: 1999-01-22
Abstract: The present invention provides a lumen support stent (20) for use in an artery or any body lumen. The stent is formed from a plurality of ladder elements (32) having elongated ribs (28) bowed to define a circumferential arc of the tubular member and end rungs (30) affixed to the elongated ribs. The elongated ribs of adjacent ladder elements are substantially parallel to one another and slidably engaged by the end rungs of adjacent ladder elements. Sliding of the end rungs along the circumferential arc defined by the engaged ribs creates a variable circumferential distance between the end rungs of adjacent ladder elements. Consequently, the stent has a first diameter in which the circumferential distance between end rungs of adjacent ladder elements is collapsed, and a variable second diameter in which the circumferential distance between end rungs of adjacent ladder elements is expanded.
Patent CA-2326959-A1 (CA)
Title: Treatments for spinal muscular atrophy
Inventor: CHANG JAN-GOWTH
IPC: A61P21/00
Filed: 2000-12-19
Abstract: The invention features a method of modulating SMN exon 7 expression in a subject by administering a histone deacetylase inhibitor.
Patent CA-2329807-A1 (CA)
Inventor: ARNDT SILKE
IPC: A61F13/15
Filed: 1999-04-23
Abstract: An absorbent article, having an absorbent capacity which is lower in the crotch region than compared to the waist regions when being loaded in a vertical arrangement, wherein the Actual Wet Crotch Caliper as determined following a Curved Acquisition Test method can be less than the Saturated Crotch Caliper, and also can be less than the Actual Wet Waist Caliper. Further, the article should have a good rewetting performance.
Patent CA-2332336-A1 (CA)
Inventor: LEROUX-ROELS GEERT
IPC: A61K35/12
Filed: 1999-05-25
Abstract: The present invention relates to a method for reconstituting immunocompromised mice with primate cells, consisting of the following steps: (a) preparation of an immunocompromised mouse by administration of an antibody against the beta chain of the mouse interleukin 2 (IL-2) receptor, more particularly the monoclonal mouse TM-.beta.1 monoclonal antibody and/or gamma irradiation, (b) intraspleen injection of primate cells into the spleen of the pre-treated immunocompromised mouse of step (a), where these primate cells preferably originate from a primate donor and where this primate donor may have been immunised with a well-defined antigen. This method was found to be highly suitable for expanding primate B lymphocytes in an animal model in a rapid, as yet unequalled manner. Other embodiments of this invention relate to immunocompromised mice obtained by the aforesaid method and also the use thereof as animal models, primate B cell culture produced and primate monoclonal antibodies derived therefrom.
Patent CA-2333170-A1 (CA)
Title: Intelligent network and packet data network interoperability
Inventor: NYBERG ANNA
IPC: H04Q3/00
Filed: 1999-05-21
Abstract: A method and system are disclosed for creating an interface (23) between a packet-switched network (16) and an IN, which is based on an interface between an associated circuit-switched network and an IN/CAMEL  service (120). Meanwhile, the CAMEL application can also provide IN services to mobile subscribers (12) while they are roaming in other networks (e.g., international roaming).
Patent CA-2334471-A1 (CA)
Inventor: STAFFORD DOUGLAS C
IPC: A61K38/00
Filed: 1999-06-07
Abstract: Methods are described for treating inflammatory bowel disease in animals, including humans. Specific avian polyclonal antibodies directed to proinflammatory cytokines (such as IL-6 and TNF) are shown to have a beneficial effect in animal models predictive of human therapy for the treatment of colitis, including Crohn's disease.
Patent CA-2334666-A1 (CA)
Title: Sealing structure for an alkali battery
Inventor: YAMAMOTO KENJI
IPC: H01M50/186
Filed: 1999-06-10
Abstract: After a negative electrode current collector (10) has been inserted into an insertion hole (28a) therein, a resin sealing element (28) and negative electrode terminal plate (12) are successively inserted into an aperture (1a) of a battery casing (1), and the aperture rim of battery casing (1) is then bent inwards and crimped to seal aperture (1a) of battery casing (1).       Sealing element (28) is accommodated within battery casing (1) in an arrangement facing negative electrode terminal plate (12), with resin injection gate (28c) corresponding to resin injection port (27a) of metal molds (22 - 24) during resin molding thereof positioned at the aperture end of battery casing (1).
Patent CA-2334882-A1 (CA)
Inventor: SHERMAN ADAM
IPC: B65D47/26
Filed: 1999-06-10
Abstract: The present invention is a self-closing cap (1, 50) which comprises a base (2, 60) having one or more holes (4, 65). A lid (10, 61) is movably mounted about the base (2, 60), said lid (10, 61) having one or more holes (11, 66), and capable of occupying a first open position and a second closed position. In the first open position, the holes (4, 65) of the base (2, 60) align with the holes (11, 66) of the lid (10, 61). In the second closed position, the holes (4, 65) of the base (2, 60) do not align with the holes (11, 66) of the lid (10, 61). A spring means (30, 90) is provided between the base (2, 60) and the lid (10, 61) in order to automatically place the lid (10, 61) in the closed position. Further, the underside of the lid (10, 61) is provided with one or more protrusions (20, 80) which seal the holes (4, 65) of the base (2, 60) when the lid (10, 61) is in the closed position.
Patent CA-2335013-A1 (CA)
Inventor: SUGERMAN HARVEY J
IPC: A61H9/00
Filed: 1999-07-16
Abstract: An abdominal decompression apparatus (Figs. 1A-2B) reduces intra-abdominal pressure in patients by application of negative pressure (22) to the patient 's abdomen. Preferably, the negative pressure is applied continuously at low negative pressures (e.g., -20 mm Hg to -40 mm Hg) for extended periods of ti me (e.g., 6 hours to 12 hours). Changes in the patient's intra-abdominal pressu re can be monitored using measurements of the patient's bladder pressure (26), and treatments can be designed to achieve decreases in bladder pressure. To alleviate pain, to permit maximum decrease in intra-abdominal pressure, a countertraction mechanism (54-70) is connected to the shell (50) which encloses the patient's abdomen, and counters the negative pressure induced downward movement of the shell on the patient's chest. The countertraction mechanism is sufficient to reduce or eliminate the negative pressure induced  downward movement but is less than an amount which would cause loss of vacuu m pressure within said shell.
Patent CA-2335376-A1 (CA)
Title: Acides nucleiques codant les recepteurs associes a la proteine g qui interviennent dans la transduction sensorielle
Inventor: LINDEMEIER JUERGEN
IPC: C12P/
Filed: 1999-07-27
Abstract: L'invention concerne des séquences isolées d'acides nucléiques et d'acides aminés de récepteurs associés à la protéine G qui sont spécifiques aux cellules sensorielles, ainsi que des anticorps vis-à-vis de ces récepteurs, et des procédés relatifs à la détection desdits acides nucléiques et récepteurs. L'invention concerne également des procédés relatifs au criblage des modulateurs du type de récepteur considéré.
Patent CA-2336071-A1 (CA)
Title: Method and device for applications of selective organ cooling
Inventor: DOBAK JOHN D III
IPC: A61F7/00
Filed: 1999-06-22
Abstract: The invention provides a method and device for heating or cooling a surrounding fluid in a feeding vessel. The device includes a catheter assembly capable of insertion to a selected feeding vessel in the vascular system of a patient. The assembly includes a heat transfer element at a distal end of the catheter assembly, the heat transfer element (14) having a plurality of exterior surface irregularities (20, 24) shaped and arranged to create turbulence in a surrounding fluid, the surface irregularities (20, 24) having a depth at least equal to the boundary layer thickness of flow of the surrounding fluid in the feeding vessel. The assembly also includes a supply catheter (12) to deliver a working fluid to an interior of the heat transfer element (14), a return catheter (202) to return a working fluid from the interior of the heat transfer element (14), and a drug delivery catheter (312) running substantially parallel to the axis of the catheter assembly.
Patent CA-2336699-A1 (CA)
Title: Method of sharing capabilities information between the nodes of a telecommunications network
Inventor: ROSENZWEIG BENITA
IPC: H04Q3/00
Filed: 1999-06-22
Abstract: A method of sharing capabilities information between a plurality of nodes in a telecommunications network. The method begins when a new node (11) is installed in the telecommunications network or the capabilities of a node are modified. The new or modified node sends an Exchange Data Directive (EXDATADIR) Invoke message (13, 24, 25) to one or more cooperating nodes (12, 21, 22) in the network. The EXDATADIR message is an intersystem node capabilities declaration message which includes parameters relating to communications capabilities and service support capabilities of the new or modified node. If the node is a new node, this is followed by sending EXDATADIR Return Result messages (15) from each cooperating node to the new node. The EXDATADIR Return Result message is an intersystem node capabilities declaration message which includes parameters relating to services supported by the cooperating nodes. Upon receipt of a node capabilities declaration message, each node updates its exchange data with the parameters relating to the capabilities of the other nodes in the network.
Patent CA-2340029-A1 (CA)
Title: Aqueous solid gel comprising a hydrophilic gelling agent, a cellulose derivative and pigments and/or mother-of-pearls and uses thereof
Inventor: BARA ISABELLE
IPC: A61K8/00
Filed: 2000-06-08
Abstract: The invention concerns an aqueous solid gel characterised in that it comprises (i) at least a hydrophilic gelling agent, (ii) at least a cellulose derivative and (iii) a powder phase comprising at least a pigment and/or mother-of-pearl, the content of the hydrophilic gelling agent/ cellulose derivative combination present in the gel being not more than 20 wt. %, relative to the gel total weight. Said gel can be used in the form of stick or waterpact and can constitute make-up products for the skin, mucous membranes and/or keratinous fibres. Said gel provides the advantage of being stable (absence of syneresis). It provides easy and homogeneous disintegration of the product and great freshness on application.
Patent CA-2340595-A1 (CA)
Title: Streptavidin mutants having secondary functional domains
Inventor: NELSON KJELL E
IPC: C07K19/00
Filed: 1999-08-25
Abstract: Streptavidin molecules are disclosed that contain a secondary functional domain. In preferred embodiments, the secondary domain is a cell adhesion peptide incorporated in the streptavidin amino acid sequence at a site not interfering with biotin binding. In a preferred embodiment, the cell adhesio n peptide is arginine-glycine-aspartate (Arg-Gly-Asp) (RGD). The peptide is preferably placed on an exposed loop of the streptavidin molecule, such as within the loop defined by residues 63 to 69. The mutant streptavidin molecu le can have other characteristics such as reduced biotin binding due to a modification of an amino acid at the biotin binding site. Preferred uses for  the disclosed streptavidin molecules are as adaptors to bring, via a streptavidin/biotin interaction, the secondary functional domain into proximity with a cell or molecule to be affected and as a coating for substrates such as vascular devices or prostheses.
Patent CA-2340647-A1 (CA)
Inventor: MOSER BRIAN ALLEN
IPC: C07K7/56
Filed: 1999-08-18
Abstract: Reversible borate or boronate complexes of 1,2-cis-diol cyclic-peptides and their use as a means for purification, isolation, stabilization and/or water solubilization of their respective parent 1,2-cis-diol cyclic-peptide is described. A method for forming the boronate adducts is also described. The method is particularly useful for forming boronate adducts of hydrophobic Echinocandin compounds to increase their water solubility. Pharmaceutical formulations and treatments based on the reversible borate or boronate complexes of active 1,2-cis-diol cyclic-peptides (e.g., Echinocandin antifungal compounds) are also described.
Patent CA-2341729-A1 (CA)
Title: Control unit for fluid control valves
Inventor: MOORE DUDLEY
IPC: E03C1/05
Filed: 1999-08-26
Abstract: Control apparatus including a plurality of fluid control valves (5), especially for supplying items of sanitary ware (1 and 2). The valves have magnetic bistable solenoid actuators drivable by pulse signals and a common control circuit (6) able to drive the actuators independently and the control circuit and actuators are driven by a local power supply including a dry cell battery (7).
Patent CA-2342682-A1 (CA)
Title: Cooling air arrangement for a heat exchanger of an aircraft air conditioning unit
Inventor: BUCHHOLZ UWE ALBERT
IPC: B64D13/00
Filed: 2001-03-29
Abstract: A cooling air arrangement for an aircraft air conditioning unit includes an air inlet, a heat exchanger, an outlet plenum, first and second air outlet channels branching from the plenum, and a fan arranged in the first outlet channel. During flight of the aircraft, external ram air driven into the air inlet flows primarily through the second outlet channel. During ground operation, the fan primarily sucks cooling air through the first outlet channel, which merges back into the second outlet channel at an air mixing junction that functions as an injector nozzle and a non-return flap valve. The first outlet channel is provided in a spiral housing of the fan, or in a smooth curved duct.      The air inlet and outlet of the cooling air arrangement, and the air outlet of the air cycle machine, are oriented in the same direction, e.g. the flight forward direction.
Patent CA-2346692-A1 (CA)
Inventor: OGURA AKIRA
IPC: B65D75/00
Filed: 1999-08-18
Abstract: A heat shrinkable film package which is formed by coating at least the entire lid (3) of a food-storing container (1) with heat shrinkable film (F), the container (1) being constituted by providing an opening (7) in a lid (3) mounted to the opening of a container body (2) so as to seal the interior thereof and by placing a non-air-permeable sheet (8), which is provided with a vent hole (12) at a position offset from the opening (7), on the outer surface of the lid (3) so as to cover and be in close contact with the opening (7).
Patent CA-2347035-A1 (CA)
Inventor: HUTTON PETER B
IPC: F16K27/00
Filed: 1999-10-19
Abstract: A valve manifold (IM) for interfacing between a flowline control manifold and first and second pressure sensor units, the manifold having a monolithic body (22) defining a mating surface (28) for mating with the process control manifold and an instrument face for mating with the first and second pressure sensor units, the body having a peripheral wall (54) with a first portion (60) thereof being on the opposite side of the instrument face with respect to the mating face, the first portion of the peripheral wall forming an equalizing valve pocket surface for high and low pressure equalizing valve pockets (76, 82) carrying high and low pressure equalizing valves (77, 79), respectively.  High and low pressure fluid passageways (72, 78) extend from the mating surface to the equalizing valve pockets. The high pressure fluid passageway communicates with a high pressure plenum (48) in the instrument face while the low pressure fluid passageway (78) communicates with a low pressure plenum (46) formed in the instrument face. An equalizing fluid passageway (102, 104) interconnects the high pressure and low pressure equalizing valve pockets. A  gauge pressure passageway (88) is connected to the high pressure fluid passageway and is in open communication with a second high pressure plenum (50) formed in the instrument face. A block valve (97) selectively controls flow through the gauge pressure passageway.
Patent CA-2348305-A1 (CA)
Inventor: MARSH BRENT
IPC: E21B17/046
Filed: 2001-05-23
Abstract: A breech lock wireline connector for connecting tools to a wireline inserted into a well bore. The connector has a housing with an axially movable plunger within the housing and each being in axial alignment. A spring is used for biasing the plunger axially toward and into engagement with the breech pin. The breech pin is selectively engageable and disengageable into lock and unlock positions, respectively, with the plunger and the housing. The plunger rotates the breech pin axially between the lock and unlock positions. A latch is provided for latching the plunger and breech pin in the lock position.
Patent CA-2351923-A1 (CA)
Title: Pressure relief valve for amplified pressure air drive diaphragm pump
Inventor: KENNEDY DENNIS EARL
IPC: F16K17/04
Filed: 1997-05-01
Abstract: A relief valve has a valve body with a cavity therein, a guideway extending to the cavity, a valve seat in the cavity and a flow path through the cavity and across the valve seat to exhaust. An actuator is slidably positioned in the guideway, and a valve element is slidably positioned in the valve body within the cavity, facing the guideway and slidable into and biased toward seating engagement with the valve seat.      A compression spring is located between the actuator and the valve element, the latter extending into the guideway from the cavity. The actuator and/or the valve element includes a spring seat to receive the compression spring and a stop to encounter the other of the actuator and the valve element with the compression spring compressed. There is a return spring between the valve body and the valve element to bias the valve element toward seating engagement with the valve seat.
Patent CA-2352339-A1 (CA)
Inventor: VAN DEN BERG KAREL
IPC: G01F1/74
Filed: 2000-09-04
Abstract: L'invention concerne un procédé servant à exécuter dans un conduit (4; 6, 23) des mesures sur un milieu constitué particulièrement par un gaz et/ou un liquide et s'écoulant, de façon pulsée, à travers ledit conduit, ce conduit (4; 6, 23) possédant une zone de mesure (17; 23) dans laquelle on détermine pendant une mesure au moins un paramètre du milieu, de façon à définir une fenêtre de mesure optimale dans laquelle on mesure le paramètre et on enregistre les données de la fenêtre de mesure et/ou on utilise ces données pour un processus ultérieur.
Patent CA-2353703-A1 (CA)
Inventor: HUSE WILLIAM D
IPC: A61K47/48
Filed: 1999-12-01
Abstract: The invention provides tumor-specific human monoclonal antibodies and functional fragments. Also provided are nucleic acids encoding tumor-specific human monoclonal antibodies and functional fragments. A method for reducing neoplastic cell proliferation is also provided. The method consists of administering an effective amount of a tumor-specific human monoclonal antibody or functional fragment. Also provided is a method of detecting a neoplastic cell in a sample. The method consists of contacting a cell with a tumor-specific monoclonal antibody or functional fragment and detecting the specific binding of the human monoclonal antibody or functional fragment to the sample.
Patent CA-2354808-A1 (CA)
Title: Sub-band adaptive signal processing in an oversampled filterbank
Inventor: BRENNAN ROBERT L
IPC: H03H17/02
Filed: 2001-08-07
Abstract: A subband adaptive signal processing system is disclosed. The system comprises an oversampled WOLA filterbank consisting of an analysis filterbank and a synthesis filterbank, wherein a plurality of short filters is utilized, each acting in its own frequency domain subband.
Patent CA-2355825-A1 (CA)
Title: Triazineone compounds for treating diseases due to sarcocystis, neospora and toxoplasma
Inventor: KENNEDY THOMAS J
IPC: A61K31/53
Filed: 1999-12-18
Abstract: Disclosed herein are methods of treating therapeutically, or metaphylactically infected animals susceptible to, or infected animal suffering from parasitic neurologic or abortigenic diseases such as Sarcocystidiae or Toxoplasmosis that are treatable with triazineone compound by administering thereto a pharmaceutically effective amount of ponazuril, including a single high dose therapeutic treatment.
Patent CA-2357509-A1 (CA)
Title: Method of forming a swimming pool construction
Inventor: HABERLER GERHARD
IPC: E04H4/00
Filed: 2001-09-17
Abstract: A swimming pool construction is of the type using metal fabricated walls and a plastics liner covering the walls and a rigid excavated pool base. The metal fabricated walls include spaced inner and outer panels defining therebetween a crawl space. The inner panels define the inner surface of the pool, The outer panels engage the surrounding soil. The panels are mounted on support members and rails supported on pairs of piles at spaced positions around the periphery of the pool. The panels are supported initially on bottom rails which are used as forms to cast a concrete layer therebetween. The panels are supported in spaced positions temporarily by a rigid arch form into which is cast a cast concrete arch allowing the rails and the arch form to be removed for re-use. The arch is cast integrally with a concrete floor which sits on supporting panels bridging the rails and resting on flat top supporting surfaces of the concrete piles. A top concrete cover is cast onto bridging panels spanning between the inner and outer walls and carried on the top of the arches.
Patent CA-2361301-A1 (CA)
Title: Apparatus and method for an accelerated thumbwheel on a communication device
Inventor: TRAN PHAT H
IPC: H04M1/247
Filed: 2001-11-07
Abstract: An accelerated roller apparatus on a handheld electronic communications device that handles urgency conditions. The device includes a manipulable mechanism that is capable of generating a manipulation-related signal. Changes in the signal occur whenever motion is imparted upon the manipulable mechanism. An urgency activity detector module generates an urgency message when the changes in the signal indicate an urgency condition. The urgency activity detector module uses the signal changes to determine the urgency condition based upon timing of successive manipulations of the manipulable mechanism satisfying a preselected timing threshold. The urgency message is then used by an application operating on the device.
Patent CA-2364948-A1 (CA)
Title: C16 unsaturated fp-selective prostaglandins analogs
Inventor: DELONG MITCHELL ANTHONY
IPC: C07C405/00
Filed: 2000-02-29
Abstract: The invention provides novel PGF analogs. In particular, the present invention relates to compounds having a structure according to formula (I), wherein R1, R2, X and Z are defined below. This invention also includes optical isomers, diastereomers and enantiomers of formula (I), and pharamceutically-acceptable salts, biohydrolyzable amides, esters, and imides thereof. The compounds of the present invention are useful for the treatment of a variety of diseases and conditions, such as bone disorders. Accordingly, the invention further provides pharmaceutical compositions comprising these compounds. The invention still further provides methods of treatment for bone disorders using theses compounds or the compositions containing them.